LD 1266 requires Maine's Attorney General to form a working group to create a plan expanding access to adult drug, family, and veterans treatment courts statewide. The group must include stakeholders like courts, corrections, health departments, prosecutors, and advocacy organizations to ensure every county has access to these specialty courts for defendants whose criminal involvement relates to substance use disorders. The working group must submit its recommendations and suggested legislation to the Judiciary Committee by January 1, 2026. This resolve does not change current law but directs a study to improve access to treatment-based court options.
LD 613 amends Maine's Death with Dignity Act to allow attending physicians to waive any portion or all of the waiting periods required for qualified patients to access end-of-life medication, based on the physician's medical assessment of the patient's condition. Physicians must document the waiver, including the specific portion waived and the medical reasoning that it serves the patient's best interests. This change directly affects patients eligible under Maine's Death with Dignity Act and their attending physicians. The amendment aims to improve timely access for patients facing urgent health circumstances without requiring the full waiting period.
LD 532 expands Maine's assault law to specifically protect all health care workers in hospital emergency rooms. The bill defines assault on these workers as a Class C crime, covering anyone employed or contracted by a state-licensed health care entity (including hospitals and clinics) while performing their job in the emergency room. This change directly affects health care workers in Maine's emergency departments by strengthening legal consequences for assaults against them. The key provision amends existing statute §752-F to broaden the definition beyond previous limitations, ensuring all licensed health care workers in emergency settings receive the same legal protection.
LD 380 amends Maine's Address Confidentiality Program to include gender-affirming health care practitioners as eligible participants, expanding the program beyond its prior focus on reproductive health care. This allows practitioners to use a designated address for mail and legal purposes, keeping their personal address confidential to enhance safety. The bill repeals prior provisions that had limited eligibility to reproductive health care practitioners and updates the program to cover both reproductive and gender-affirming services. The change is administrative and does not regulate the provision of health care services.
This bill amends Maine's paid family and medical leave laws to clarify employee leave options and strengthen program administration. It specifies that employees may take leave in hourly increments only if agreed upon with their employer, and creates a dedicated Bureau of Paid Family and Medical Leave within the Department of Labor to manage the program. The bill adds enforcement tools for unpaid employer payments, including civil lawsuits and property levies, and holds successor businesses liable for unpaid premiums from acquired employers. It also establishes fines for employers whose private leave plans lapse during approved substitutions, with collected fines directed to the state fund. These changes primarily affect Maine employers participating in the paid leave program and employees seeking leave benefits.
LD 1154 requires healthcare providers to inform women seeking an abortion for a fetus diagnosed with a lethal fetal anomaly (a condition likely to cause the baby's death within three months after birth) about perinatal hospice services as part of the informed consent process. Providers must discuss these services in person at least 24 hours before the procedure and provide a written list of available perinatal hospice providers, which the state will maintain. If the woman declines hospice services and chooses to proceed with the abortion, she must sign a written certification confirming her decision. This requirement does not apply in cases of medical emergencies or for abortions related to ectopic pregnancy or spontaneous miscarriage.
LD 1007 requires healthcare professionals in Maine to provide specific information during informed consent for drug-induced abortions. It mandates that providers inform patients about the potential for reversal if they change their mind (noting time sensitivity), and that initial studies suggest no increased maternal mortality or birth defect risks from reversal. Providers must also give patients a written statement with a website and helpline number (to be updated annually by the Department of Health) for information on abortion pill reversal services. This bill directly affects women seeking drug-induced abortions and their healthcare providers in Maine.
LD 1899 creates a new deduction for Maine state income tax on medical and dental expenses paid by taxpayers or their spouses/dependents. It allows a deduction for expenses that qualify under federal tax law (Internal Revenue Code), even if they don't meet the federal threshold or weren't claimed on federal returns. The deduction applies to expenses not covered by insurance and is effective for tax years beginning January 1, 2026. This directly affects individual Maine taxpayers who pay for healthcare costs, expanding their state tax relief beyond federal requirements.
LD 544 exempts sales of cannabis for medical use from Maine's sales tax, creating tax parity with prescription medicines. The bill amends Maine's tax code to include medical cannabis sales (after January 1, 2026) under the existing exemption for prescription medicines sold by doctors. It directly affects patients certified for medical cannabis use under Maine's Medical Use of Cannabis Act and providers selling to them. This policy change removes a sales tax burden currently applied to medical cannabis, aligning its tax treatment with other prescribed medicines. The exemption applies only to cannabis sold with a medical provider's certification, not recreational sales.
LD 1333 updates Maine's Paid Family and Medical Leave program to clarify eligibility and administration. It requires employees to have worked for an employer for at least 120 days to qualify, shortens the deadline for filing leave applications from 90 to 30 days after leave begins, and adjusts employer contribution rules: companies with 15+ workers can deduct 50% of premiums from employee wages and send 100% to the fund, while smaller employers send 50%. The bill also specifies that leave under this program runs concurrently with federal FMLA, and defines "self-employed" to include small business owners with fewer than 15 employees. These changes directly affect Maine workers seeking leave and their employers managing contributions.
